Nurse-Led Self-Management and Breathing Intervention in Type 2 Diabetes
Evaluation of Cardiovascular Insult Associated With Autonomic Dysfunction in Type 2 Diabetes Mellitus and the Effect of a Structured Nurse-Led Home-Based Intervention: A Two-Phase Analytical Study
1 other identifier
interventional
80
1 country
1
Brief Summary
Brief Summary This study evaluated the effect of a structured nurse-led home-based self-management and paced-breathing intervention on cardiovascular autonomic function and blood pressure among adults with type 2 diabetes mellitus. Participants with type 2 diabetes were randomly assigned in a 1:1 ratio to either an intervention group or a control group. The intervention included a structured home-based walking program, paced breathing at six breaths per minute, blood pressure and heart rate self-monitoring, lifestyle counseling, behavioral reinforcement, and weekly telephone follow-up by a nurse. Outcomes were assessed at baseline and at Weeks 4, 8, and 12.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Nov 2023
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 11, 2024
CompletedFirst Submitted
Initial submission to the registry
September 23, 2026
CompletedFirst Posted
Study publicly available on registry
September 29, 2026
CompletedSeptember 30, 2026
September 1, 2026
5 months
September 23, 2026
September 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Root Mean Square of Successive Differences (rMSSD) of Heart Rate Variability
rMSSD was used as a time-domain measure of heart rate variability reflecting cardiac parasympathetic autonomic activity. Higher rMSSD values indicate greater beat-to-beat heart rate variability and stronger parasympathetic modulation. Changes in rMSSD were evaluated across the study period to determine the effect of the nurse-led home-based intervention on cardiovascular autonomic function.
Time Frame: Baseline, Week 4, Week 8, and Week 12
Secondary Outcomes (2)
Change in Systolic Blood Pressure
Baseline, Week 4, Week 8, and Week 12
Change in Low-Frequency to High-Frequency Heart Rate Variability Ratio (LF/HF)
Baseline, Week 4, Week 8, and Week 12
Study Arms (2)
Nurse-Led Home-Based Intervention
EXPERIMENTALParticipants assigned to the intervention group received a 12-week structured nurse-led home-based self-management program. The program included regular home-based walking, paced breathing exercises at approximately six breaths per minute, blood pressure and heart rate self-monitoring, individualized lifestyle and diabetes self-management counseling, behavioral reinforcement, and weekly telephone follow-up by a nurse.
Usual Care Control
NO INTERVENTIONParticipants assigned to the control group continued to receive usual diabetes care and routine clinical follow-up. They did not receive the structured nurse-led home-based self-management and paced-breathing program during the 12-week study period.
Interventions
A 12-week nurse-led home-based intervention designed to improve cardiovascular autonomic function and cardiovascular self-management among adults with type 2 diabetes mellitus. The intervention consisted of regular home-based walking, paced breathing exercises performed at approximately six breaths per minute, self-monitoring of blood pressure and heart rate, individualized education and lifestyle counseling, behavioral reinforcement, and weekly telephone follow-up by a nurse.
Eligibility Criteria
You may qualify if:
- Male participants aged 35-55 years.
- Documented diagnosis of type 2 diabetes mellitus for at least 1 year.
- Receiving stable pharmacological treatment for at least 3 months before enrollment.
- Clinically stable at the time of assessment.
- Willing to participate and provide written informed consent.
You may not qualify if:
- Current or previous smoking.
- Ischemic heart disease.
- Cardiac arrhythmias.
- Chronic liver disease.
- Chronic kidney disease.
- Neurological disorders unrelated to diabetes.
- Use of medications known to substantially influence autonomic nervous system function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Nursing
Study Record Dates
First Submitted
September 23, 2026
First Posted
September 29, 2026
Study Start
November 12, 2023
Primary Completion
April 9, 2024
Study Completion
June 11, 2024
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share